Y Hirakawa
Overview
Explore the profile of Y Hirakawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
943
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mukai N, Doi Y, Ninomiya T, Hata J, Hirakawa Y, Fukuhara M, et al.
Diabet Med
. 2011 Jul;
29(1):99-106.
PMID: 21726278
Aims: We examined the optimal cut-off values of fasting plasma glucose, 2-h post-load glucose and HbA(1c) for predicting Type 2 diabetes in community-dwelling Japanese subjects. Methods: A total of 1982...
12.
Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Iwase M, et al.
Diabet Med
. 2011 Jul;
29(1):107-14.
PMID: 21718358
Aims: Risk scoring methods are effective for identifying persons at high risk of Type 2 diabetes mellitus, but such approaches have not yet been established in Japan. Methods: A total...
13.
Nakajima F, Hirakawa Y, Kaneta T, Imasaka T
Anal Chem
. 2011 Jun;
71(13):2262-5.
PMID: 21662778
A new type of chemical sensor based on light absorption is proposed. An array of zones alternatively containing the pH indicator thymolphthalein is formed in a gelatin film. By changing...
14.
Hirakawa Y, Nagai A, Muraoka K, Okada T, Maeda M
Opt Lett
. 2009 Oct;
18(9):735-7.
PMID: 19802256
Tunable coherent extreme-ultraviolet (XUV) radiation at wavelengths as low as 66.86 nm was generated by two-photon resonant four-wave mixing in a hydrogen molecular gas jet. In this investigation, an ArF...
15.
Prasankumar R, Hirakawa Y, Kowalevicz Jr A, Kaertner F, Fujimoto J, Knox W
Opt Express
. 2009 May;
11(11):1265-9.
PMID: 19465993
We describe an extended cavity femtosecond Cr:LiSAF laser pumped by inexpensive single spatial mode diodes. Using a multi-pass cavity (MPC) to lower the repetition rate and a saturable Bragg reflector...
16.
Hirakawa Y, Shimokawa H
Clin Calcium
. 2005 Mar;
11(4):463-8.
PMID: 15775543
Although anti-atherosclerotic effects of Ca channel antagonists have been shown in animal studies, clinical trials have failed to show such effects in humans. In those clinical studies, Ca channel antagonists...
17.
Sakai N, Sendo T, Itoh Y, Hirakawa Y, Takeshita A, Oishi R
J Clin Pharm Ther
. 2003 Dec;
28(6):505-12.
PMID: 14651675
Objective: The incidence of and risk factors for delayed adverse events (DAEs) that appear from 1 h to 7 days after injection of radiographic contrast media were investigated in patients...
18.
Hosokawa S, Tagawa T, Niki H, Hirakawa Y, Nohga K, Nagaike K
Br J Cancer
. 2003 Oct;
89(8):1545-51.
PMID: 14562030
We have recently established a cancer-reactive human monoclonal antibody, GAH, with a positive ratio of over 90% against stomach cancer. GAH was formulated as polyethyleneglycol (PEG)-modified immunoliposomal doxorubicin (DXR) (ILD)...
19.
Hirakawa Y, Nakamura K, Imasaka T
Anal Chem
. 2002 Jan;
73(22):5472-6.
PMID: 11816576
Phosphor materials that were manufactured for use in a plasma display panel (PDP) were investigated by employing a newly designed time-resolved vacuum-ultraviolet (VUV) spectrometer, which consists of a pulsed VUV...
20.
Hirakawa Y, Shimokawa H
Nihon Yakurigaku Zasshi
. 2002 Jan;
118(6):389-95.
PMID: 11778457
Accumulating evidences in recent major clinical studies have shown the importance of anti-hyperlipidemic treatment in preventing atherosclerotic cardiovascular diseases. Lipid-lowering drugs can be divided into HMG-CoA reductase inhibitors (statins), bile-acid...